Login
Home
Charts
Search
Watchlist
Products

Indogulf Cropsciences Ltd

IGCL·NSE
63.55-2.00%Wed, 23 Sept '26

Indogulf Cropsciences Ltd

IGCL
NSE
63.55
-2.00%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
400Cr
Close
Close Price
63.21
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
12.20
PS
Price To Sales
0.58
Revenue
Revenue
684Cr
Rev Gr TTM
Revenue Growth TTM
5.58%
PAT Gr TTM
PAT Growth TTM
13.44%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
13913223399126189248116151169
Growth YoY
Revenue Growth YoY%
-9.143.36.717.019.5-11.0
Expenses
ExpensesCr
11912620589105179216104130159
Operating Profit
Operating ProfitCr
2062710211032122010
OPM
OPM%
14.64.511.810.116.55.212.910.113.55.7
Other Income
Other IncomeCr
3211212321
Interest Expense
Interest ExpenseCr
3334445445
Depreciation
DepreciationCr
3232323343
PBT
PBTCr
182235155277143
Tax
TaxCr
5161516421
PAT
PATCr
131174104214122
Growth YoY
PAT Growth YoY%
-24.3186.724.15.518.5-37.7
NPM
NPM%
9.31.07.23.77.82.08.33.37.71.4
EPS
EPS
4.90.04.00.92.00.81.70.82.30.4
QuarterMar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
13913223399126189248116151169
Growth YoY
Revenue Growth YoY%
-9.143.36.717.019.5-11.0
Expenses
ExpensesCr
11912620589105179216104130159
Operating Profit
Operating ProfitCr
2062710211032122010
OPM
OPM%
14.64.511.810.116.55.212.910.113.55.7
Other Income
Other IncomeCr
3211212321
Interest Expense
Interest ExpenseCr
3334445445
Depreciation
DepreciationCr
3232323343
PBT
PBTCr
182235155277143
Tax
TaxCr
5161516421
PAT
PATCr
131174104214122
Growth YoY
PAT Growth YoY%
-24.3186.724.15.518.5-37.7
NPM
NPM%
9.31.07.23.77.82.08.33.37.71.4
EPS
EPS
4.90.04.00.92.00.81.70.82.30.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
467487550552590705684
Growth
Revenue Growth%
4.312.80.56.919.35.6
Expenses
ExpensesCr
429440501493526631610
Operating Profit
Operating ProfitCr
39474959647474
OPM
OPM%
8.39.78.910.810.910.510.8
Other Income
Other IncomeCr
2330588
Interest Expense
Interest ExpenseCr
561213151718
Depreciation
DepreciationCr
691010111112
PBT
PBTCr
30363036455352
Tax
TaxCr
8988131313
PAT
PATCr
22262228314039
Growth
PAT Growth%
18.3-14.925.911.527.213.4
NPM
NPM%
4.85.44.15.15.35.75.6
EPS
EPS
9.511.29.512.06.56.75.2
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
467487550552590705684
Growth
Revenue Growth%
4.312.80.56.919.35.6
Expenses
ExpensesCr
429440501493526631610
Operating Profit
Operating ProfitCr
39474959647474
OPM
OPM%
8.39.78.910.810.910.510.8
Other Income
Other IncomeCr
2330588
Interest Expense
Interest ExpenseCr
561213151718
Depreciation
DepreciationCr
691010111112
PBT
PBTCr
30363036455352
Tax
TaxCr
8988131313
PAT
PATCr
22262228314039
Growth
PAT Growth%
18.3-14.925.911.527.213.4
NPM
NPM%
4.85.44.15.15.35.75.6
EPS
EPS
9.511.29.512.06.56.75.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
242424244963
Reserves
ReservesCr
130157180208226396
Current Liabilities
Current LiabilitiesCr
230208281281364348
Non Current Liabilities
Non Current LiabilitiesCr
262534294816
Total Liabilities
Total LiabilitiesCr
411414518542688823
Current Assets
Current AssetsCr
311323421452559666
Non Current Assets
Non Current AssetsCr
100909790129158
Total Assets
Total AssetsCr
411414518542688823
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
242424244963
Reserves
ReservesCr
130157180208226396
Current Liabilities
Current LiabilitiesCr
230208281281364348
Non Current Liabilities
Non Current LiabilitiesCr
262534294816
Total Liabilities
Total LiabilitiesCr
411414518542688823
Current Assets
Current AssetsCr
311323421452559666
Non Current Assets
Non Current AssetsCr
100909790129158
Total Assets
Total AssetsCr
411414518542688823

Cash Flow

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
20-7-5753-15-41
Investing Cash Flow
Investing Cash FlowCr
-10-10-19-5-40-37
Financing Cash Flow
Financing Cash FlowCr
-91675-496180
Net Cash Flow
Net Cash FlowCr
1-1-1-173
Free Cash Flow
Free Cash FlowCr
10-19-7747-55
CFO To PAT
CFO To PAT%
90.9-26.6-254.2188.9-46.9-101.7
CFO To EBITDA
CFO To EBITDA%
52.6-14.8-116.689.8-23.0-55.0
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
20-7-5753-15-41
Investing Cash Flow
Investing Cash FlowCr
-10-10-19-5-40-37
Financing Cash Flow
Financing Cash FlowCr
-91675-496180
Net Cash Flow
Net Cash FlowCr
1-1-1-173
Free Cash Flow
Free Cash FlowCr
10-19-7747-55
CFO To PAT
CFO To PAT%
90.9-26.6-254.2188.9-46.9-101.7
CFO To EBITDA
CFO To EBITDA%
52.6-14.8-116.689.8-23.0-55.0

Ratios

Consolidated
Standalone
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
373400
Price To Earnings
Price To Earnings
9.312.2
Price To Sales
Price To Sales
0.50.6
Price To Book
Price To Book
0.80.9
EV To EBITDA
EV To EBITDA
7.38.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
32.721.221.123.825.0
OPM
OPM%
8.39.78.910.810.910.510.8
NPM
NPM%
4.85.44.15.15.35.75.6
ROCE
ROCE%
15.114.510.512.511.811.011.0
ROE
ROE%
14.514.611.012.211.48.78.7
ROA
ROA%
5.46.44.35.24.64.94.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
373400
Price To Earnings
Price To Earnings
9.312.2
Price To Sales
Price To Sales
0.50.6
Price To Book
Price To Book
0.80.9
EV To EBITDA
EV To EBITDA
7.38.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
32.721.221.123.825.0
OPM
OPM%
8.39.78.910.810.910.510.8
NPM
NPM%
4.85.44.15.15.35.75.6
ROCE
ROCE%
15.114.510.512.511.811.011.0
ROE
ROE%
14.514.611.012.211.48.78.7
ROA
ROA%
5.46.44.35.24.64.94.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Indogulf Cropsciences is an Indian agri-solutions platform that covers the full crop lifecycle, from pre-sowing to yield enhancement, with crop protection products, plant nutrients, and biologicals. It began in 1993 as a pesticide formulator and has spent three decades evolving into a backward-integrated manufacturer of its own active ingredients, now reaching farmers in over 34 countries. The recurring approach is to build manufacturing depth first, then layer on distribution reach and farmer engagement - a model that turns chemical production capability into a direct relationship with the grower. # Business segments A single agri-solutions engine with three product verticals - crop protection, biologicals, and plant nutrients - that share the same manufacturing backbone, R&D lab, and distribution network, with crop protection as the foundation that carries the other two. ## 1. Crop protection: the manufacturing and distribution engine **A backward-integrated maker of insecticides, fungicides, and herbicides that sells through three channels - direct to farmers, to institutions, and overseas - with increasing control over its own raw materials.** - **Makes its own active ingredients** - the Nathupur II plant manufactures technical-grade chemicals like Bifenthrin and Cloquintocet, so the company is not solely dependent on buying intermediates from others; captive consumption of these technicals has climbed from 22% to roughly 32% in recent quarters. - **Four plants, each with a job** - Nathupur I handles formulation (13,500 MT/KL capacity), Nathupur II does technical manufacturing and backward integration (1,360 TPA), Barwasni runs advanced formulations (20,064 MT/KL), and Samba in Jammu & Kashmir adds strategic manufacturing (9,000 MT/KL), together spread across about twenty acres. - **Three routes to the customer** - the B2C channel (about half of revenue) sells branded products through 7,000-plus distributors and a field force of 331 people across 22 states, giving better realizations and farmer connect; the B2B channel (about 38%) supplies 192 institutional partners with contract-manufactured technicals, adding scale and plant utilization; exports (about 11%) reach 34-plus countries through 140-plus overseas partners. - **Registrations are the entry ticket** - the company holds 732 crop protection product registrations, with 138 more in the pipeline, and a new pesticide management bill with mandatory QR tagging and digital traceability is expected to raise barriers for smaller, unorganized competitors. - **R&D that has already produced patents** - a team of eight scientists working out of a NABL-certified lab in Nathupur has generated six product patents since 2019, including a formulation patent in 2024 and a process patent for sulphur needle control in paddy, with a strategy that spans short-term registrations, mid-term technology transfer, and long-term new-molecule discovery. ## 2. Biologicals: the sustainability layer on the same network **Bio-fertilizers and bio-stimulants that ride the crop-protection distribution engine to reach farmers looking for residue-free and stress-tolerant solutions.** - **A small but fast-acceptance portfolio** - with 19 product registrations and key brands like INDO APACHE and ROOT-O-MAX GOLD, this vertical helps farmers improve nutrient uptake and cope with drought and heat stress, and it has already passed field trials in Sri Lanka for export. - **Research backed by a government fellowship** - a February 2026 agreement with ICAR-IARI under the Prime Minister’s Fellowship for Doctoral Research funds a full-time PhD scholar through 2029, focused specifically on bio-stimulants for alleviating drought and heat stress in plants. - **No separate go-to-market** - the biologicals reach farmers through the same 7,000-plus distributor B2C network, the same IDO (Independent Distributor/Dealer Operator) network of over 100 operators, and the same institutional and export channels as crop protection, so adoption does not require building a new sales force. ## 3. Plant nutrients: soil health sold through the same pipe **Straight and specialty fertilizers, micronutrients, and deficiency correctors that complete the crop-cycle offering and are now reaching new export markets.** - **Completes the crop-cycle story** - products like ZINC SUPER GOLD and PICASO ULTRA address soil fertility and stress management, so the company can sell to a farmer from pre-sowing through growth to yield enhancement without leaving the nutrient piece to a competitor. - **First Latin American shipment** - the company executed its inaugural fertilizer shipment to Venezuela during FY26, opening a new geography for a portfolio that holds 189 total registrations. - **Manufactured on the same four-plant base** - the nutrient products are made across the same facilities that run crop protection and biologicals, with the same zero-discharge approach where effluents are collected, treated, and reused, and the same ISO 9001, 14001, and 45001 certifications. # Group structure and partners **A family-promoted company with two wholly owned subsidiaries that extend its reach - one into OECD markets, the other into underserved Indian farm belts - plus a research partnership with India’s premier agricultural institute.** - **Indogulf Cropsciences Australia Pty Ltd** - incorporated in Sydney in 2019, this subsidiary handles registrations in OECD-compliant markets, clearing the regulatory path for exports into developed-country markets. - **Abhiprakash Globus Private Limited (AGPL)** - a Delhi-based subsidiary operating under the “Giraffe” brand, it reaches farmers beyond the existing Indogulf network by appointing secondary distributors in previously inaccessible territories, contributing 9% of revenue as of late 2025 while also absorbing spare manufacturing capacity. - **Promoter group with deep roots** - the Agarwal family has over four decades in agrochemicals, with group operations dating back to 1954 and other group companies that include Insecticides India Limited, HPM Chemicals and Fertilizers Limited, Ichiban Crop Science Limited and Crystal Crop Protection Limited.

Documents — Indogulf Cropsciences Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/edifkeisu4t9z5tlue03le4j.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/46oj3orqdtfu0ndy7q3o19cm.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/28yqb2jcf1mtsixlwru9dlsu.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/iztqbwa1oilg7546unzbhg1q.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/69clyet1td4q4xmf1ohg0ltv.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/wnd9fvwoiq3nj6o7hlgok9bo.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/7vue6snftps4mtdf8we94u4w.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/v6rlbazv1huk0lronypnzohp.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/scajpjtrji3o5y1e49733z4k.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/inxd8jbvckmvds6vsncc63hl.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/2fe5jmhh307g7n7h2mat5z6f.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/1haq9wsx20ist3yotzgnxec1.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/9mbp3nv0vpffb4ytu0ebl1mz.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/qxpov4tnmi2k4rblrejawj1z.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/j8x28c1pmw299ukcsiq4pekl.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/xmthcgkn5a6bnjue2fmyr0z7.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/i3ryafiuasyrr4ewmxr02vtx.pdf

Concall Transcript Summaries — Indogulf Cropsciences Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AIGCL/transcript-notes/202606/edifkeisu4t9z5tlue03le4j.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AIGCL/transcript-notes/202603/46oj3orqdtfu0ndy7q3o19cm.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3AIGCL/transcript-notes/202512/28yqb2jcf1mtsixlwru9dlsu.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AIGCL/transcript-notes/202509/iztqbwa1oilg7546unzbhg1q.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AIGCL/transcript-notes/202506/69clyet1td4q4xmf1ohg0ltv.pdf